Skip to main content

CCTG Connection



Published:
Category: Group updates
CCTG Pharmacy Network seeking pharmacy representation
The CCTG Pharmacy Network is actively seeking pharmacy representation for: Pharmacist Representative for the Lung Committee and Pharmacist Representatives for the Steering Group a 2nd Ontario Rep Read More

Published:
Category: Group updates
Request for Applications: Patient Representatives Committee Chair

The Canadian Cancer Trials Group (CCTG) is requesting applications for the volunteer position of Chair of the Patient Representative Committee. 

Read More

Published:
Category: News
Marathon of Hope Cancer Centres Network and Canadian Cancer Trials Group partner pan-Canadian projects

A new partnership between the Marathon of Hope Cancer Centres Network (MOHCCN) and the Canadian Clinical Trials Group (CCTG) will support three pan-Canadian research teams aiming to better understand how immunotherapies can best be used to increase survival, reduce toxicities and improve quality of life for cancer patients in Canada.

Read More

Published:
Category: News
Can melanoma biomarkers guide duration of immunotherapy treatment

Melanoma is the deadliest form of skin cancer, and prior to 2010, outcomes were extremely poor for most patients with metastatic melanoma, where their cancer had spread to other parts of their body. Encouragingly, a class of treatments called immune checkpoint inhibitors (ICIs) dramatically improved survival for some patients, even leading to cures in some cases. However, some patients do not respond to ICI therapy and others experience severe side-effects.

Read More

Published:
Category: News
Canadian framework to improve predictive models for immunotherapy interventions (CAN-PREDICT-IT)

In recent years, immunotherapies have emerged as a promising class of cancer drugs that harnesses the power of the immune system to fight cancer. But despite their life-saving potential, their effectiveness is limited: only 20 to 30 per cent of people with cancer benefit from them and some experience severe side effects without any therapeutic benefit.

Read More

Published:
Category: News
Canadian Platform to Investigate Primary and Acquired Resistance to Cancer Immunotherapy (CAN-PIVOT)

Immunotherapy is an innovative type of cancer treatment that harnesses the patient's own immune system to recognize and eliminate cancer cells. In the last decade, the use of immunotherapy has increased exponentially, and it is now applied as the treatment of choice in many different cancer types. This popularity comes from the remarkable results seen in some patients treated with immunotherapy, which can lead to a cure in some cases and significantly prolong patient lives in others.

Read More

Published:
Category: Publications
Publication: MA27
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27
 
Chapman J-AW, Bayani J, SenGupta S, Bartlett JMS, Piper T, Quintayo MA, Virk S, Goss PE, Ingle JN, Ellis MJ, Sledge GW, Budd GT, Rabaglio M, Ansari RH, Tozer R, D'Souza DP, Chalchal h, Spadafora S, Stearns V, Perez EA, Gelmon KA, Whelan TJ, Elliott C, Shepherd LE, Chen BE, Taylor KJ.
Read More



Published:
Category: Group updates
Welcome to Patient Representative Deb Clark - Gynecologic Disease site committee

The CCTG Patient Representative Committee is pleased to welcome Deb Clark who will support the Gynecologic Disease site committee. Deb lives in Regina and her journey began when her mom was diagnosed with ovarian cancer, now a 26-year cancer survivor. Deb supported her mom as her caregiver through three additional, primary cancers and was her husband’s caregiver when he had oral cancer. 

Read More